Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17090742 | 0.98 | MEN1 (0.36) | MEN1KMT2AS1PR1 | |
| SCHEMBL17090720 | 0.95 | MEN1 (0.33) | MEN1KMT2A | |
| SCHEMBL17090750 | 0.84 | MEN1 (0.37) | MEN1KMT2AS1PR1 | |
| SCHEMBL2814490 | 0.83 | TSHR (0.35) | MEN1KMT2A | |
| SCHEMBL17090729 | 0.82 | MEN1 (0.38) | MEN1KMT2AS1PR1 | |
| SCHEMBL17090737 | 0.79 | NOS3 (0.32) | — | |
| SCHEMBL19096030 | 0.71 | SLC18A3 (0.34) | MEN1KMT2A | |
| SCHEMBL28033277 | 0.71 | SLC18A3 (0.41) | MEN1KMT2A | |
| SCHEMBL14673079 | 0.71 | TSHR (0.34) | MEN1KMT2A | |
| SCHEMBL23071376 | 0.70 | CYP11B2 (0.47) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150291728-A1 | EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION | DAICEL CORPORATION (JP) | 2015-10-15 | — | — | US | disclosed |
| EP-2921513-A1 | EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION | Daicel Corporation (JP) | 2015-09-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291728-A1 | EPOXY COMPOUND, PRODUCTION METHOD THEREFOR, AND CURABLE EPOXY RESIN COMPOSITION | CBR1, SEM1, EEF1A1 | MEN1 2699/4885KMT2A 901/4885S1PR1 1934/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.